ADM Co-occurring Disorders & Dual Diagnosis Flashcards
6 cards from real ADM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 ADM Co-occurring Disorders & Dual Diagnosis flashcards as text
Which screening tool is commonly used to identify depression in patients with substance use disorders?
Answer: PHQ-9
The PHQ-9 (Patient Health Questionnaire-9) is a validated, widely used screening tool for depression in patients with substance use disorders.
When assessing a dual diagnosis patient, which factor is most important before diagnosing a primary psychiatric disorder?
Answer: A period of sobriety to clarify substance-free psychiatric status
A period of sobriety is needed to determine whether psychiatric symptoms are substance-induced or represent an independent primary disorder, as many symptoms resolve with abstinence.
Which antidepressant class is generally preferred for treating depression in patients with alcohol use disorder due to its safety profile?
Answer: Selective serotonin reuptake inhibitors (SSRIs)
SSRIs are preferred in patients with alcohol use disorder due to their favorable safety profile, lower overdose risk, and fewer dangerous interactions with alcohol.
What is the primary clinical concern with using benzodiazepines for chronic anxiety management in patients with non-alcohol substance use disorders?
Answer: High risk of dependence and cross-addiction
Benzodiazepines carry a high risk of dependence and cross-addiction in patients with existing substance use disorders, making them generally avoided for chronic anxiety management.
Which evidence-based integrated psychotherapy was specifically developed to treat co-occurring PTSD and substance use disorders simultaneously?
Answer: Seeking Safety
Seeking Safety is an evidence-based integrated therapy specifically designed to address co-occurring PTSD and substance use disorders at the same time.
Which mood stabilizer has evidence supporting its use in patients with co-occurring bipolar disorder and alcohol use disorder, potentially reducing both mood symptoms and drinking?
Answer: Valproate (divalproex)
Valproate (divalproex) is FDA-approved for bipolar disorder and has evidence showing it may reduce both mood symptoms and alcohol consumption in co-occurring AUD.